Metabolic signatures and potential biomarkers for the diagnosis and treatment of colon cancer cachexia
Cancer cachexia (CAC) is a debilitating condition that often arises from noncachexia cancer (NCAC), with distinct metabolic characteristics and medical treatments. However, the metabolic changes and underlying molecular mechanisms during ca...
Main Authors: | Qiu Xu, Lu Ruohan, He Qiqing, Chen Shu, Huang Caihua, Lin Donghai |
---|---|
Format: | Article |
Language: | English |
Published: |
China Science Publishing & Media Ltd.
2023-09-01
|
Series: | Acta Biochimica et Biophysica Sinica |
Subjects: | |
Online Access: | https://www.sciengine.com/doi/10.3724/abbs.2023151 |
Similar Items
-
Biomarkers for Cancer Cachexia: A Mini Review
by: Zhipeng Cao, et al.
Published: (2021-04-01) -
Discovery of serum biomarkers for diagnosis of tuberculosis by NMR metabolomics including cross-validation with a second cohort
by: R. Conde, et al.
Published: (2022-08-01) -
Metabolomics analysis reveals novel serum metabolite alterations in cancer cachexia
by: Tushar H. More, et al.
Published: (2024-02-01) -
NMR-Based Metabolomic Analysis for the Effects of α-Ketoglutarate Supplementation on C2C12 Myoblasts in Different Energy States
by: Yantong Li, et al.
Published: (2021-03-01) -
Cancer Cachexia and Related Metabolic Dysfunction
by: Guilherme Wesley Peixoto da Fonseca, et al.
Published: (2020-03-01)